Scintigraphic Load of Bone Disease Evaluated by DASciS Software as a Survival Predictor in Metastatic Castration-resistant Prostate Cancer Patients Candidates to 223RaCl Treatment

BACKGROUND: Aim of our study was to assess the load of bone disease at starting and during Ra-223 treatment as an overall survival (OS) predictor in metastatic castration-resistant prostate cancer (mCRPC) patients. Bone scan index (BSI) is defined as the percentage of total amount of bone metastasis...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiol Oncol
Main Authors: Frantellizzi, Viviana, Pani, Arianna, Ippoliti, Maria Dea, Farcomeni, Alessio, Aloise, Irvin, Colosi, Mirco, Polito, Claudia, Pani, Roberto, Vincentis, Giuseppe De
Format: Artigo
Jezik:Inglês
Izdano: Sciendo 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087429/
https://ncbi.nlm.nih.gov/pubmed/31855572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2019-0058
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki